Filtronic plc (FLTCF)

Market Cap	414.83M
Revenue (ttm)	75.89M
Net Income (ttm)	18.93M
Shares Out	n/a
EPS (ttm)	0.08
PE Ratio	21.91
Forward PE	41.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,486
Average Volume	2,686
Open	1.981
Previous Close	2.030
Day's Range	1.970 - 1.981
52-Week Range	0.859 - 2.350
Beta	0.57
RSI	43.78
Earnings Date	Jul 29, 2025

About Sage Therapeutics

Filtronic plc designs, develops, manufactures, and sells radio frequency (RF) technology in the United Kingdom, Europe, the Americas, and internationally. It provides Morpheus II and X2, an E-band transceiver module; Cerus, an E-brand power amplifier for long range communications; Hercules II, a high power E-band transreceiver; Taurus, an E-brand power amplifier; Hades and Hades X2, an E-band active diplexer; tower top amplifiers; and transmit and receive modules. The company also offers custom products, such as waveguide diplexers; cross-band ...

• Industry: Communication Equipment
• Sector: Technology
• Founded: 1977
• Employees: 133
• Stock Exchange: OTCMKTS
• Ticker Symbol: FLTCF

Financial Performance

In 2025, Filtronic's revenue was 56.32 million, an increase of 121.45% compared to the previous year's 25.43 million. Earnings were 14.05 million, an increase of 347.28%.